Cue Health Product Strategy Guide | Digital Health Evolution

Executive Summary

In 2025, Cue Health stands at a pivotal moment in its transformation from a COVID-19 testing pioneer to a comprehensive digital health platform. The company's strategic evolution reveals three critical shifts:

1. Diversification beyond COVID-19: Expanding test menu to include flu, RSV, and other infectious diseases.
2. Vertical integration: Developing in-house manufacturing capabilities to reduce costs and improve supply chain resilience.
3. Data-driven healthcare: Leveraging vast amounts of collected health data to provide personalized insights and predictive analytics.

Cue Health has captured approximately 15% of the at-home diagnostic testing market, with revenue reaching $500 million in 2024. However, the company faces intensifying competition from both established medical device manufacturers and agile startups.

As the healthcare industry undergoes rapid transformation towards decentralized, patient-centric care, Cue Health is positioning itself as the leader in accessible, actionable health information. The company's strategic direction focuses on creating an ecosystem of connected diagnostic devices, supported by AI-powered analytics, to empower individuals in managing their health proactively.

Introduction

Cue Health's recent decision to acquire a small AI startup specializing in predictive health analytics marks a significant shift in the company's product strategy. This move reflects the broader industry trend towards integrating artificial intelligence and machine learning into diagnostic platforms, enhancing their predictive capabilities and clinical value.

As the dust settles from the COVID-19 pandemic, Cue Health faces several key strategic questions:

1. How can the company maintain growth as COVID-19 testing demand declines?
2. What new product lines will drive future revenue and market expansion?
3. How can Cue Health differentiate itself in an increasingly crowded at-home diagnostics market?
4. What partnerships or acquisitions will be crucial for long-term success?

This analysis will explore Cue Health's current product landscape, short-term priorities, mid-term outlook, and long-term vision to answer these questions. By examining the company's strategic choices, market positioning, and technological investments, we'll uncover the roadmap Cue Health is likely to follow in its quest to revolutionize personal health monitoring.

Cue Health's Current Product Landscape

Cue Health's product portfolio in 2025 is built around its core Cue Reader platform, with a growing ecosystem of test cartridges and digital health services. Here's a breakdown of the company's revenue streams:

1. Cue Reader and COVID-19 tests: 45% of revenue
2. Expanded test menu (flu, RSV, STIs): 30% of revenue
3. Enterprise solutions and partnerships: 15% of revenue
4. Digital health services and subscriptions: 10% of revenue

In the at-home diagnostic market, Cue Health holds approximately 15% market share, trailing behind industry leader Abbott (25%) but ahead of emerging competitors like Lucira Health (8%) and Ellume (6%).

Recent win/loss analysis reveals:

• Win: Secured a major contract with a national pharmacy chain for in-store Cue Health kiosks, expanding accessibility and brand awareness.
• Loss: Failed to win a government contract for next-generation rapid testing platforms, losing to a competitor with a more diverse test menu.

Strategic Position Matrix:

Expert perspective: "According to a former Cue Health Product leadership executive, 'The company's biggest challenge is transitioning from a COVID-19 testing company to a comprehensive health information platform. Success hinges on rapidly expanding the test menu while building out the digital ecosystem.'"

Short-Term: The Next 12 Months

Cue Health's short-term strategy revolves around three key themes:

1. Test Menu Expansion

   • Launch of combination COVID-19/Flu/RSV test cartridge
   • Introduction of at-home STI testing panel
   • Development of hormone and vitamin deficiency tests

2. Digital Platform Enhancement

   • Integration of AI-powered health insights into Cue Health app
   • Launch of telemedicine services for test result follow-ups
   • Implementation of blockchain technology for secure health data sharing

3. Manufacturing Optimization

   • Completion of new automated production facility to reduce costs
   • Streamlining of supply chain through strategic partnerships

Success metrics include:

• 30% year-over-year growth in non-COVID test sales
• 50% increase in monthly active users of Cue Health app
• 20% reduction in manufacturing costs

Expected market impact: These initiatives should solidify Cue Health's position as a leader in at-home diagnostics while paving the way for expansion into broader digital health services.

Strategic Dialogue Section: "When discussing Cue Health's immediate priorities with industry experts, three key questions emerged:

1. How will Cue Health maintain relevance post-COVID?
2. Can the company successfully transition to a subscription-based model?
3. What partnerships are crucial for expanding the test menu?

Here's how Cue Health appears to be addressing each:

1. By rapidly expanding its test menu and enhancing its digital platform, Cue Health is positioning itself as an essential tool for ongoing health monitoring, not just COVID-19 testing.

2. The company is introducing tiered subscription plans that bundle device access, a set number of tests per month, and premium digital health features to create recurring revenue streams.

3. Cue Health is actively pursuing partnerships with specialized diagnostic companies to accelerate the development of new test cartridges, particularly in areas like cardiac health and cancer screening."

Mid-Term: 1-5 Year Outlook

In the mid-term, Cue Health is making several strategic bets:

1. Expansion into continuous glucose monitoring (CGM) for diabetes management
2. Development of a next-generation Cue Reader with enhanced connectivity and processing power
3. Creation of a B2B platform for employers and insurers to manage population health

Key build vs. buy decisions on the horizon:

• Build: Next-generation Cue Reader and core testing technologies
• Buy: Advanced AI capabilities for predictive analytics
• Partner: For rapid expansion of specialized test menu items

Potential market entries:

• Prescription drug monitoring
• Personalized nutrition recommendations based on microbiome testing
• Mental health tracking through hormone and neurotransmitter analysis

Strategic Framework Analysis: "Using the Strategy Triangle framework:

📌 Where to Play: Cue Health is focusing on the intersection of at-home diagnostics, digital health platforms, and personalized medicine. The company is targeting health-conscious consumers, chronic disease patients, and enterprise clients looking for population health solutions.

📌 How to Win: By leveraging its established brand in COVID-19 testing, Cue Health aims to become the go-to platform for comprehensive health monitoring. The company's competitive advantage lies in its integrated hardware-software approach, providing actionable insights from a wide range of diagnostic tests.

📌 Why Now: The pandemic has accelerated the adoption of telemedicine and at-home diagnostics. Consumers are increasingly comfortable with managing their health remotely, creating a unique opportunity for Cue Health to establish itself as the leader in this emerging space."

Long-Term: 5-10 Year Projection

Cue Health's long-term strategy is built on several core assumptions about market evolution:

1. Personalized medicine will become the standard of care, driven by advances in genomics and AI.
2. Healthcare will continue to decentralize, with more diagnostic and monitoring tasks performed at home.
3. Consumers will demand greater control over their health data and seek integrated platforms for health management.

Major technology bets:

• Investment in quantum computing for complex health data analysis
• Development of non-invasive testing methods using advanced spectroscopy
• Integration of augmented reality for intuitive result interpretation and health coaching

Potential disruption factors:

• Breakthrough in CRISPR technology enabling at-home genetic modifications
• Emergence of brain-computer interfaces for direct health monitoring
• Regulatory changes affecting direct-to-consumer health testing

Expert insights: Former Senior Executive 1: "Cue Health's success will depend on its ability to transition from a hardware-centric model to a data-centric one. The real value lies in the insights we can provide from the vast amount of health data we're collecting."

Former Senior Executive 2: "I believe Cue Health has the potential to become the 'Apple of healthcare' – creating an ecosystem of devices and services that seamlessly integrate into people's lives. The key will be maintaining the balance between innovation and regulatory compliance."

Strategic Recommendations

1. Prioritize the development of a next-generation Cue Reader with expanded capabilities, aiming for launch within 18 months.
2. Accelerate partnerships with specialized diagnostic companies to rapidly expand the test menu, targeting 50 different tests within 3 years.
3. Invest heavily in AI and machine learning capabilities to enhance predictive analytics and personalized health insights.
4. Explore strategic acquisitions in the digital therapeutics space to complement diagnostic offerings.

Success metrics to watch:

• Monthly active users of Cue Health platform
• Revenue per user
• Number of tests performed per user per month
• Enterprise client retention rate

Key risks and mitigation strategies:

• Regulatory hurdles: Maintain open dialogue with FDA and proactively address potential concerns
• Data privacy concerns: Implement state-of-the-art encryption and give users granular control over data sharing
• Supply chain disruptions: Diversify suppliers and increase vertical integration

Timeline of expected strategic shifts:

• Year 1-2: Focus on test menu expansion and digital platform enhancement
• Year 3-4: Launch next-generation Cue Reader and enter continuous monitoring market
• Year 5+: Expand into digital therapeutics and explore international markets

Key Takeaways

The most important strategic moves to watch for Cue Health are:

1. The successful launch and adoption of the next-generation Cue Reader
2. Expansion into continuous health monitoring, particularly for chronic diseases
3. Strategic partnerships or acquisitions in AI and digital therapeutics

Key metrics that will indicate success/failure:

• Growth in non-COVID test sales as a percentage of total revenue
• User engagement metrics, particularly tests per user per month
• Success rate in obtaining FDA approvals for new tests

Bottom Line: Cue Health's future hinges on its ability to transform from a COVID-19 testing company into a comprehensive health information platform. The company's strong brand recognition and established user base provide a solid foundation, but success will depend on rapid innovation, strategic partnerships, and the ability to navigate complex regulatory landscapes. If executed well, Cue Health has the potential to become a central player in the future of personalized, proactive healthcare management.

RELATED GUIDES

📖 Cue Health Product Manager Interview Guide – Hiring process & role insights.

📖 Cue Health Product Manager Salary Guide – Salary insights & negotiation tips.

📖 Cue Health Product Teardown Guide – Deep dive into Cue Health's product strategy.

Disclaimer: This guide is created for product management interview preparation purposes only. The analysis and predictions are speculative and should not be considered as financial advice or an accurate representation of Cue Health's actual strategy. This content should not be used as the basis for any investment decisions. All product plans and strategies discussed are based on public information and industry analysis, not insider knowledge.